Literature DB >> 11164694

The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women.

H E Jones1, N Haug, K Silverman, M Stitzer, D Svikis.   

Abstract

This study examined the effectiveness of short-term contingency management for eliminating cocaine use and increasing full day treatment attendance with pregnant methadone-maintained women randomly assigned to either an escalating voucher incentive schedule (n=44) or non-incentive (n=36) conditions. Full day treatment attendance and urine toxicology for cocaine and heroin were assessed and consequated for 14 days. The escalating voucher incentive schedule significantly increased full day treatment attendance and drug abstinence compared to the non-incentive schedule. These results suggest that reinforcing the co-occurrence of two required behaviors (treatment attendance and abstinence from illicit drug use) is effective, and may be an important adjunct to methadone pharmacotherapy for treating pregnant drug dependent women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164694     DOI: 10.1016/s0376-8716(00)00152-6

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  48 in total

Review 1.  A review of exercise as intervention for sedentary hazardous drinking college students: rationale and issues.

Authors:  Jeremiah Weinstock
Journal:  J Am Coll Health       Date:  2010 May-Jun

Review 2.  Monetary-based consequences for drug abstinence: methods of implementation and some considerations about the allocation of finances in substance abusers.

Authors:  Jesse Dallery; Bethany Raiff
Journal:  Am J Drug Alcohol Abuse       Date:  2011-12-13       Impact factor: 3.829

Review 3.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 4.  Contingency management interventions for tobacco and other substance use disorders in pregnancy.

Authors:  Dennis J Hand; Jennifer D Ellis; Meagan M Carr; Diane J Abatemarco; David M Ledgerwood
Journal:  Psychol Addict Behav       Date:  2017-06-22

Review 5.  Recent advances in the psychotherapy of addictive disorders.

Authors:  Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 6.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

Review 7.  Substance Use in the Perinatal Period.

Authors:  Ariadna Forray; Dawn Foster
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

8.  The relationship between maternal methadone dose at delivery and neonatal outcome: methodological and design considerations.

Authors:  Hendrée E Jones; Lauren M Jansson; Kevin E O'Grady; Karol Kaltenbach
Journal:  Neurotoxicol Teratol       Date:  2013 Sep-Oct       Impact factor: 3.763

9.  Disseminating contingency management: impacts of staff training and implementation at an opiate treatment program.

Authors:  Bryan Hartzler; T Ron Jackson; Brinn E Jones; Blair Beadnell; Donald A Calsyn
Journal:  J Subst Abuse Treat       Date:  2013-12-21

Review 10.  Evaluation and management of opioid dependence in pregnancy.

Authors:  Eliza M Park; Samantha Meltzer-Brody; Joji Suzuki
Journal:  Psychosomatics       Date:  2012-08-14       Impact factor: 2.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.